Event details are as follows:
October 5, 2021 , at4:00 PM EDT (1:00 PM PDT ). For this event, Renmark is focused on attracting participants in theGreater Los Angeles area, though other interested parties are welcome to attend. REGISTER HERE: https://www.renmarkfinancial.com/live-registration/renmark-virtual-non-deal-roadshow-tsx-hls-2021-10-05-130000October 7, 2021 , at12:00 PM EDT . For this event, Renmark is focused on attracting participants in theGreater Atlanta area, though other interested parties are welcome to attend. REGISTER HERE: https://www.renmarkfinancial.com/live-registration/renmark-virtual-non-deal-roadshow-tsx-hls-2021-10-07-120000
The events will feature
To ensure smooth connectivity, please access the links using the latest version of
ABOUT
Formed in 2015, HLS is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. HLS's focus is on products targeting the central nervous system and cardiovascular therapeutic areas. HLS's management team is composed of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages. For more information, please visit: www.hlstherapeutics.com
SOURCE
© Canada Newswire, source